HIV Treatment Adherence Dose Determination Trial
DOSE DETERMINATION TRIAL: The Start/Persist Studies
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Confirmed HIV positive * Confirmed prescribed antiretroviral therapy * Confirmed non-adherent to anti-retroviral therapy Exclusion Criteria: * Does not have access to a phone * Does not have access to the internet
About the study
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
What is being tested
- Behavioral Self-Regulation Adherence Counseling (behavioral)
Sponsor: University of Connecticut · Participants: 400 · Started: Sep 1, 2020
Contact the study team
- Seth Kalichman, PhD · Phone: 860 208 3706
Official record on ClinicalTrials.gov — NCT04577313
Locations in the U.S.
| Connecticut | University of Connecticut, Storrs |
| Georgia | University of Connecticut Field Site, Atlanta |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.